Steven Julious
0000-0002-9917-7636
University of Sheffield
121 papers found
Refreshing results…
Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit–risk assessment: the BRAINS study including expert workshop
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials
A retrospective analysis of conditional power assumptions in clinical trials with continuous or binary endpoints
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
Developing guidance for a risk-proportionate approach to blinding statisticians within clinical trials: a mixed methods study
TRial to Assess Implementation of New research in a primary care Setting (TRAINS): study protocol for a pragmatic cluster randomised controlled trial of an educational intervention to promote asthma prescription uptake in general practitioner practices
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT
A descriptive study of samples sizes used in agreement studies published in the PubMed repository
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
An investigation of the constancy of effect in Cochrane systematic reviews in context with the assumptions for noninferiority trials
Blinding of study statisticians in clinical trials: a qualitative study in UK clinical trials units
A practical guide to sample size calculations: Installation of the app SampSize
Expected Value of Sample Information to Guide the Design of Group Sequential Clinical Trials
Adjusting for bias in the mean for primary and secondary outcomes when trials are in sequence
Sample sizes for cluster-randomised trials with continuous outcomes: Accounting for uncertainty in a single intra-cluster correlation estimate
Utilising benefit-risk assessments within clinical trials—a protocol for the BRAINS project
A systematic review of the “promising zone” design
Self-managed, computerised word finding therapy as an add-on to usual care for chronic aphasia post-stroke: An economic evaluation
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
Missing publications? Search for publications with a matching author name.